NAU’s Pathogen and Microbiome Institute to test Allarity Therapeutics drug as potential therapy for new, highly infectious Coronavirus Variant B117

The testing plan for the “British variant” is based on findings of pre-clinical tests showing stenoparib blocks infection and the replication of SARS-CoV-2, as recently published in peer-reviewed journal mBio.

Read more

Rutgers Black Physician Shares Why She Joined Coronavirus Vaccine Clinical Trial

As the United States begins rolling out coronavirus vaccines, many people, especially those in the Black community, are still hesitant to participate when it becomes widely available. Valerie Fitzhugh, a Rutgers doctor discusses why she chose to participate in a coronavirus vaccine trial as a Black woman, wife, and mother of two children and encourages more people, particularly minorities, to be vaccinated.

Read more

UCLA to lead statewide coalition to address COVID-19’s impact on communities at risk

A coalition of 11 academic institutions and their community partners across California has received a $4.1 million grant from the NIH for a statewide community-engaged approach to addressing COVID-19 among populations that have been disproportionately affected by the pandemic.

Read more

Rutgers Experts Explore Questions, Concerns Over COVID-19 Vaccine Trials

As researchers race to develop a COVID-19 vaccine, a Rutgers infectious disease expert and a Rutgers bioethicist discuss how clinical trials work, the ethics of developing and distributing a vaccine, safety and efficacy in clinical trials and what a successful vaccine may mean.

Read more